Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Trinity Bio ADR (TRIB)

Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,575
  • Shares Outstanding, K 7,622
  • Annual Sales, $ 56,830 K
  • Annual Income, $ -24,020 K
  • 60-Month Beta 1.24
  • Price/Sales 0.22
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TRIB with:

Options Overview Details

View History
  • Implied Volatility 137.50% ( -266.08%)
  • Historical Volatility 44.36%
  • IV Percentile 19%
  • IV Rank 4.40%
  • IV High 1,373.82% on 02/15/24
  • IV Low 80.66% on 06/23/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 539
  • Open Int (30-Day) 544

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6500 +3.03%
on 05/10/24
1.9696 -13.69%
on 04/29/24
-0.2290 (-11.87%)
since 04/10/24
3-Month
1.6500 +3.03%
on 05/10/24
3.1000 -45.16%
on 02/12/24
-0.9885 (-36.77%)
since 02/09/24
52-Week
1.6500 +3.03%
on 05/10/24
5.5000 -69.09%
on 07/05/23
-3.3250 (-66.17%)
since 05/10/23

Most Recent Stories

More News
Trinity Biotech Announces Quarter 1 2022 Financial Results

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.7000 (+3.03%)
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product,...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces The Successful Closing of its Debt Refinancing

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022

DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.7000 (+3.03%)
Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes

DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products...

TRIB : 1.7000 (+3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Key Turning Points

3rd Resistance Point 1.7833
2nd Resistance Point 1.7467
1st Resistance Point 1.7233
Last Price 1.7000
1st Support Level 1.6633
2nd Support Level 1.6267
3rd Support Level 1.6033

See More

52-Week High 5.5000
Fibonacci 61.8% 4.0293
Fibonacci 50% 3.5750
Fibonacci 38.2% 3.1207
Last Price 1.7000
52-Week Low 1.6500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar